Detalles de la búsqueda
1.
Genomic and Glycolytic Entropy Are Reliable Radiogenomic Heterogeneity Biomarkers for Non-Small Cell Lung Cancer.
Int J Mol Sci
; 24(4)2023 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36835402
2.
Predicting the risk of interval distant metastases in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy.
J Formos Med Assoc
; 121(2): 539-545, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34167877
3.
Prospective comparison of early interim 18F-FDG-PET with 18F-FLT-PET for predicting treatment response and survival in metastatic breast cancer.
BMC Cancer
; 21(1): 908, 2021 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34376155
4.
Comparison of 18F-FDG PET/MRI, MRI, and 18F-FDG PET/CT for the detection of synchronous cancers and distant metastases in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.
Eur J Nucl Med Mol Imaging
; 47(1): 94-104, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31606831
5.
Value of early evaluation of treatment response using 18F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma.
Eur J Nucl Med Mol Imaging
; 46(3): 650-660, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30264225
6.
Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer.
BMC Cancer
; 19(1): 1167, 2019 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31791269
7.
Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma.
Eur J Nucl Med Mol Imaging
; 45(8): 1297-1308, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29502310
8.
Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
Eur Radiol
; 26(11): 4162-4172, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26911889
9.
Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma.
World J Surg Oncol
; 12: 170, 2014 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-24885430
10.
Interval between neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma: does delayed surgery impact outcome?
Ann Surg Oncol
; 20(13): 4245-51, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23959050
11.
Baseline and interim [18F]FDG-PET/MRI to assess treatment response and survival in patients with M0 esophageal squamous cell carcinoma treated by curative-intent therapy.
Cancer Imaging
; 23(1): 109, 2023 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37932848
12.
18F-Fluorodeoxyglucose PET/CT for Early Prediction of Outcomes in Patients with Advanced Lung Adenocarcinomas and EGFR Mutations Treated with First-Line EGFR-TKIs.
Cancers (Basel)
; 14(6)2022 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35326662
13.
Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma.
Ann Nucl Med
; 36(3): 256-266, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34817824
14.
Prospective Investigation of 18FDG-PET/MRI with Intravoxel Incoherent Motion Diffusion-Weighted Imaging to Assess Survival in Patients with Oropharyngeal or Hypopharyngeal Carcinoma.
Cancers (Basel)
; 14(24)2022 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36551590
15.
MRI Radiomics for Predicting Survival in Patients with Locally Advanced Hypopharyngeal Cancer Treated with Concurrent Chemoradiotherapy.
Cancers (Basel)
; 14(24)2022 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36551604
16.
Association of early changes of circulating cancer stem-like cells with survival among patients with metastatic breast cancer.
Ther Adv Med Oncol
; 14: 17588359221110182, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35860832
17.
PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma.
Eur J Nucl Med Mol Imaging
; 38(6): 996-1008, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21327634
18.
¹8F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.
Eur J Nucl Med Mol Imaging
; 38(9): 1607-19, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21567252
19.
Multiparametric positron emission tomography/magnetic resonance imaging in nasopharyngeal carcinoma: Correlations between magnetic resonance imaging functional parameters and 18F-fluorodeoxyglucose positron emission tomography imaging biomarkers and their predictive value for treatment failure.
Tzu Chi Med J
; 33(1): 61-69, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33505880
20.
Combing MRI Perfusion and 18F-FDG PET/CT Metabolic Biomarkers Helps Predict Survival in Advanced Nasopharyngeal Carcinoma: A Prospective Multimodal Imaging Study.
Cancers (Basel)
; 13(7)2021 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33800542